[At the time of this podcast Paxlovid had just come out and I said that it was a drug very much like Tamiflu (Bloomberg had it right!). I had a hunch that it was going to be a failure like Tamiflu. We are already starting to see signs that my hunch was correct.]
Update: The bad news keeps coming for Paxlovid . https://www.forbes.com/sites/brucelee/2022/07/31/biden-covid-19-positive-again-is-paxlovid-rebound-more-common-than-claimed/
https://www.webmd.com/lung/news/20220630/fauci-paxlovid-rebound-worse-symptoms Fauci claims the drug worked like it was supposed to . Uhhh, okay ?
Originally posted March 15, 2021 . Much more info in the podcast.
Old post starts here:
I have been going back in time, thanks to the magic of the internet, and it’s been very interesting and eye-opening. What have I been researching? Well, it was definitely not what I had planned to do today, but I started by watching a video on Youtube about 9/11. In that CBS news video they mentioned and showed Donald Rumsfeld. I couldn’t remember what he was ‘known’ for , so I Googled it. I was surprised to see that his name was linked to Gilead, a biotech/pharmaceutical company. That lead me to Wikipedia where I started clicking links about Gilead, biotech company startups and investors and other people and finally ended up at this article after about 3 hours of reading , with a few breaks in between.
This article is truly jaw-dropping, to me, at least. Definitely adds credence to the verse that says money is the root of all kinds of evil. Please read it and let me know what you think. I will post a few excerpts below.
The U.S. first began stockpiling Tamiflu and Relenza back in 2005, in the wake of concern that an outbreak in Southeast Asia of bird flu, a far more deadly form of the disease, might go global. On November 1, 2005, President George W.Bush pronounced pandemic flu a “danger to our homeland,” and he asked Congress to approve legislation that included $1billion for the production and stockpiling of antivirals. This was after Congress had already approved $1.8billion to stockpile Tamiflu for the military, a decision that was made during the tenure of Defense Secretary Donald Rumsfeld. (Before joining the Bush Cabinet, Rumsfeld was chairman for four years of Gilead Sciences, the company that holds the patent on Tamiflu, and he held millions of dollars’ worth of stock in the company. According to Roll Call, an online newspaper covering events on Capitol Hill, Rumsfeld says he recused himself from all government decisions involving Tamiflu. Gilead’s stock price rose more than 50 percent in 2005, when the government’s plan was announced.)
As with vaccines, the scientific evidence for Tamiflu and Relenza is thin at best.
As late as this August, the company’s own Web site contained the following statement, which was written under the direction of the FDA: “Tamiflu has not been proven to have a positive impact on the potential consequences (such as hospitalizations, mortality, or economic impact) of seasonal, avian, or pandemic influenza.” An FDA spokesperson said recently that the agency is unaware of any data submitted by Roche that would support the claims in the company’s September 2006 news release about the drug’s reducing flu deaths.https://www.theatlantic.com/magazine/archive/2009/11/does-the-vaccine-matter/307723/
Listen to this information and more on this podcast episode.
And post-script, how many ended up dying from Swine flu , H1N1 in 2009? According to the CDC, 12,469, no more than the deaths from seasonal flu.
On August 10, 2010, WHO declared an end to the global 2009 H1N1 influenza pandemic. However, the virus continues to circulate as a seasonal flu virus, and cause illness, hospitalization, and deaths worldwide every year.
From April 12, 2009 to April 10, 2010, the CDC estimates there were 60.8 million cases (range: 43.3 – 89.3 million), 274,304 hospitalizations (range: 195,086 – 402,719), and 12,469 deaths (range: 8868 – 18,306) in the United States due to the virus.
A follow-up study done in September 2010 showed that the risk of serious illness resulting from the 2009 H1N1 flu was no higher than that of the yearly seasonal flu. For comparison, the CDC estimates the global H1N1 death toll at 284,000 and the WHO estimates that 250,000 to 500,000 people die of seasonal flu annually.https://en.wikipedia.org/wiki/2009_swine_flu_pandemic_in_the_United_States
NOTE: In this podcast I mention ‘covid pills’. At that time I didn’t know the name of them, but I was talking about Paxlovid which is what is still being used at this writing despite early signs that the drug is not working.
In this analysis, 1,039 patients had received Paxlovid, and 1,046 patients had received placebo and among these patients, 0.8% who received Paxlovid were hospitalized or died during 28 days of follow-up compared to 6% of the patients who received placebo. The safety and effectiveness of Paxlovid for the treatment of COVID-19 continue to be evaluated.https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19
The resistance studies come on the heels of other recent concerns about Paxlovid, which in the United States remains restricted to use in people with risk factors making them more likely to develop severe COVID-19. Confirming anecdotal reports widely reported by media, several studies have found a small percentage of infected people who receive the normal 5-day course initially feel better, only to have their symptoms rebound. And questions have grown about whether Paxlovid helps those who aren’t at high risk of serious disease—Pfizer earlier this month halted a large trial of the drug in standard risk COVID-19 patients because it was failing to show statistically significant protection against death or hospitalization.https://www.science.org/content/article/bad-news-paxlovid-coronavirus-can-find-multiple-ways-evade-covid-19-drug